Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

143.97
+7.355.38%
Post-market: 144.580.6088+0.42%17:21 EDT
Volume:15.38M
Turnover:2.24B
Market Cap:57.48B
PE:-17.98
High:149.73
Open:137.91
Low:135.01
Close:136.62
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:4.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.50
PE(LYR):-19.83

Loading ...

Polymarket Odds: Will MRNA, XOM, CVX Beat Earnings Tomorrow?

TIPRANKS
·
Jul 31

Moderna Targets Ebola With New mRNA Vaccine Trial: What Investors Should Watch

TIPRANKS
·
Jul 31

US Fusion Energy Company Commonwealth Raises $1 Billion in Equity Funding

Reuters
·
Jul 30

Stock Track | Moderna Soars 5.20% Intraday on Goldman Sachs Target Hike and Flu Vaccine Optimism

Stock Track
·
Jul 27

Movement Alert|Moderna, Inc. Rises 5.15% in Regular Trading, Goldman Sachs Target Price Hike and Flu Vaccine Approval Expectations Fuel Rebound

Market Focus
·
Jul 27

Moderna Inc. Stock Falls 5.2%, Underperforms Peers

Dow Jones
·
Jul 25

Cboe data shows mixed options sentiment in Moderna with shares down 4.65%

TIPRANKS
·
Jul 25

Stock Track | Moderna Plunges 5.15% Intraday as Cautious Analyst Views and Q2 Earnings Jitters Mount

Stock Track
·
Jul 24

Movement Alert|Moderna, Inc. Falls 5.07% in Regular Trading, Cautious Analyst Expectations Weigh Ahead of Q2 Earnings

Market Focus
·
Jul 24

Barclays Reaffirms Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
Jul 24

Moderna (MRNA) Receives a Hold from Bernstein

TIPRANKS
·
Jul 23

Cboe data shows mixed options sentiment in Moderna with shares down 1.48%

TIPRANKS
·
Jul 23

Biotech Experts Want FDA Drug Reviews Based on Science, not Politics

Reuters
·
Jul 22

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Moderna Inc. Stock Slides 3.8%, Underperforms Peers

Dow Jones
·
Jul 21

Moderna Says Curevac Broke Agreement by Suing over COVID Vaccine Patents

Reuters
·
Jul 21

Goldman Sachs Adjusts Moderna Price Target to $67 From $49, Maintains Neutral Rating

MT Newswires Live
·
Jul 20

Moderna President Stephen Hoge Disposes of Common Shares Worth $3.61 Million

Reuters
·
Jul 17

Moderna Inc. Stock Sheds 7.5%, Underperforms Peers

Dow Jones
·
Jul 17

Movement Alert|Moderna Falls 5.52% in Regular Trading, Patent Settlement Payment Pressure Sparks Market Concern

Market Focus
·
Jul 16